Christopher Brett Primiano, VP, General COUNSEL & SECRETARY at Karyopharm Therapeutics Inc. (KPTI), bought 1,000 shares at $26.75 ($27K) on 2014-05-13, disclosed to the SEC on 2014-05-13.
Open-market purchase of $27k KPTI by VP, General COUNSEL & SECRETARY. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |